Growth Metrics

Neogenomics (NEO) Deferred Taxes (2022 - 2026)

Neogenomics filings provide 5 years of Deferred Taxes readings, the most recent being $769000.0 for Q1 2026.

  • On a quarterly basis, Deferred Taxes rose 42.14% to $769000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $3.6 million, a 27.38% increase, with the full-year FY2025 number at $3.4 million, up 9.41% from a year prior.
  • Deferred Taxes hit $769000.0 in Q1 2026 for Neogenomics, down from $2.7 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $5.7 million in Q2 2022 to a low of -$869000.0 in Q3 2025.
  • Median Deferred Taxes over the past 5 years was $1.8 million (2023), compared with a mean of $2.0 million.
  • The widest YoY moves for Deferred Taxes: up 109.05% in 2025, down 456.15% in 2025.
  • Neogenomics' Deferred Taxes stood at $3.3 million in 2022, then plummeted by 45.34% to $1.8 million in 2023, then fell by 14.18% to $1.6 million in 2024, then surged by 73.14% to $2.7 million in 2025, then crashed by 71.46% to $769000.0 in 2026.
  • The last three reported values for Deferred Taxes were $769000.0 (Q1 2026), $2.7 million (Q4 2025), and -$869000.0 (Q3 2025) per Business Quant data.